SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced it will report financial results for the third quarter of 2018 after market close on Thursday, November 29, 2018.
November 7, 2018
· 1 min read